Basel Medical Group Ltd - May 29, 2025

Speaking on behalf of the Board and the management team, BMGL’s Chief Executive Officer, Dr. Darren Chhoa, provided an update on the company's performance.

“While recent movements in our share price may raise questions, I want to assure our shareholders and stakeholders that the fundamentals of BMGL remain strong and resilient. Our financial performance continues to be robust, with our subsidiaries winning new sizable contracts particularly in the supply chain, and we remain on track with our acquisition growth strategy.”

“We believe that the recent share price decline does not reflect the intrinsic value of our business nor the solid progress we’ve made. BMGL has consistently demonstrated strong operational execution, disciplined capital management, and a commitment to delivering sustainable value for shareholders.”